Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1967 Aug 5;3(5561):338–341. doi: 10.1136/bmj.3.5561.338

Progestin therapy of breast cancer: comparison of agents.

B A Stoll
PMCID: PMC1841969  PMID: 6029163

Full text

PDF
338

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkins H. Carcinoma of the breast. Ann R Coll Surg Engl. 1966 Mar;38(3):133–153. [PMC free article] [PubMed] [Google Scholar]
  2. DOUGLAS M., LORAINE J. A., STRONG J. A. Studies with 19-norethisterone oenanthate in mammary carcinoma. Proc R Soc Med. 1960 Jun;53:427–431. [PMC free article] [PubMed] [Google Scholar]
  3. Diczfalusy E. Probable mode of action of oral contraceptives. Br Med J. 1965 Dec 11;2(5475):1394–1399. doi: 10.1136/bmj.2.5475.1394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. EISALO A., JAERVINEN P. A., LUUKKAINEN T. HEPATIC IMPAIRMENT DURING THE INTAKE OF CONTRACEPTIVE PILLS: CLINICAL TRIAL WITH POSTMENOPAUSAL WOMEN. Br Med J. 1964 Aug 15;2(5406):426–427. doi: 10.1136/bmj.2.5406.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GOLDZIEHER J. W. NEWER DRUGS IN ORAL CONTRACEPTION. Med Clin North Am. 1964 Mar;48:529–545. doi: 10.1016/s0025-7125(16)33479-4. [DOI] [PubMed] [Google Scholar]
  6. HUGGINS C., MOON R. C., MORII S. Extinction of experimental mammary cancer. I. Estradiol-17beta and progesterone. Proc Natl Acad Sci U S A. 1962 Mar 15;48:379–386. doi: 10.1073/pnas.48.3.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. JOLLES B. Progesterone in the treatment of advanced malignant tumours of breast, ovary and uterus. Br J Cancer. 1962 Jun;16:209–221. doi: 10.1038/bjc.1962.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. JONSSON U., COLSKY J., LESSNER H. E., ROATH O. S., ALPER R. G., JONES R., Jr Clinical and pharmacological observations of the effects of 9-alpha-bromo-11-beta-ketoprogesterone in patients with carcinoma of the breast. Cancer. 1959 May-Jun;12(3):509–520. doi: 10.1002/1097-0142(195905/06)12:3<509::aid-cncr2820120310>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  9. Kim U. Pituitary function and hormonal therapy of experimental breast cancer. Cancer Res. 1965 Aug;25(7):1146–1161. [PubMed] [Google Scholar]
  10. NATHANSON I. T. Clinical investigative experience with steroid hormones in breast cancer. Cancer. 1952 Jul;5(4):754–762. doi: 10.1002/1097-0142(195207)5:4<754::aid-cncr2820050416>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  11. NISSEN-MEYER R., SANNER T. THE EXCRETION OF OESTRONE, PREGNANEDIOL AND PREGNANETRIOL IN BREAST CANCER PATIENTS. I. EXCRETION AFTER SPONTANEOUS MENOPAUSE. Acta Endocrinol (Copenh) 1963 Nov;44:325–333. doi: 10.1530/acta.0.0440325. [DOI] [PubMed] [Google Scholar]
  13. STERENTAL A., DOMINGUEZ J. M., WEISSMAN C., PEARSON O. H. Pituitary role in the estrogen dependency of experimental mammary cancer. Cancer Res. 1963 Mar;23:481–484. [PubMed] [Google Scholar]
  14. STRUTHERS R. A. Post-menopausal oestrogen production. Br Med J. 1956 Jun 9;1(4979):1331–1335. doi: 10.1136/bmj.1.4979.1331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Stoll B. A. Corticosteroids in Therapy of Advanced Mammary Cancer. Br Med J. 1963 Jul 27;2(5351):210–214. doi: 10.1136/bmj.2.5351.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. YOUNG S., COWAN D. M., SUTHERLAND L. E. The histology of induced mammary tumours in rats. J Pathol Bacteriol. 1963 Apr;85:331–340. doi: 10.1002/path.1700850210. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES